triplet result

chr	position	strand	gene	transcript	miRBase ID	miRBase Accession	gain/loss	cancer	drug	detail
chr2	202030269	+	CFLAR	NM_001202515	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001202516	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001202519	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001308042	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001351590	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001202517	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001127183	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001202518	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001351593	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_003879	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	202030269	+	CFLAR	NM_001351594	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View
chr2	204169194	+	CYP20A1	NM_177538	hsa-miR-486-5p	MIMAT0002177	Loss	LGG	Temozolomide	View

Page 1 / 1 Total